Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Delcath Systems (DCTH) Preferred Shares Issued (2017 - 2019)

Delcath Systems' quarterly Preferred Shares Issued came in at -$35000.0 in Q4 2019, down 103.48% year-on-year from $1.0 million in Q4 2018, and down 100.13% quarter-over-quarter from $26.4 million in Q3 2019.

Delcath Systems has reported Preferred Shares Issued for 3 years, with the latest figure at -$35000.0 in Q4 2019.

  • For the quarter ending Q4 2019, Preferred Shares Issued fell 103.48% year-over-year to -$35000.0; the trailing twelve-month figure through Sep 2020 stood at -$35000.0 (down 100.13% YoY), and the FY2019 full-year result was $26.5 million, up 2534.33% from the prior year.
  • Preferred Shares Issued for Q4 2019 stood at -$35000.0, down from $26.4 million in the prior quarter.
  • The five-year high for Preferred Shares Issued was $26.4 million in Q3 2019, with the low at -$2.3 million in Q4 2017.
  • Average Preferred Shares Issued over 3 years is $5.0 million, with a median of $150000.0 recorded in 2019.
  • Year-over-year, Preferred Shares Issued jumped 144.12% in 2018 and tumbled 103.48% in 2019.
  • Tracing DCTH's Preferred Shares Issued over 3 years: stood at -$2.3 million in 2017, then jumped by 144.12% to $1.0 million in 2018, then slumped by 103.48% to -$35000.0 in 2019.
  • The last three Preferred Shares Issued figures came in at -$35000.0 (Q4 2019), $26.4 million (Q3 2019), and $150000.0 (Q1 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares Issued (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Delcath Systems 383.27 Mn 293.95 Mn 21.26 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2019 -35,000.00
Dec 31, 2019 -35,000.00
Sep 30, 2019 26.36 Mn
Sep 30, 2019 26.36 Mn
Mar 31, 2019 150,000.00
Mar 31, 2019 150,000.00
Dec 31, 2018 1.01 Mn
Dec 31, 2018 1.01 Mn
Dec 31, 2017 -2.28 Mn
Dec 31, 2017 -2.28 Mn